Cardinal Health, Inc. (cah)

CAH — Company Overview

Cardinal Health, Inc. (CAH) trades on NYQ as part of the Healthcare peer group (Medical Distribution).

CAH — Business Description

CAH represents a Medical Distribution business in the Healthcare segment. Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospita…

Official website: https://www.cardinalhealth.com.

CAH — Investment Thesis

At a high level, CAH offers exposure to Healthcare with metrics outlined below from public market data.

• Revenue is expanding at roughly 5.8% year-over-year (public data).
• Trailing P/E of 30.69× sits in a moderate band relative to high-growth peers.
• Forward P/E (15.72×) is below trailing P/E — earnings may be expected to improve.
• Dividend yield near 0.9% adds an income component to total return.
• Equity market capitalization is approximately $51.24B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

CAH — Financial Health

Key financial health indicators for Cardinal Health, Inc. are derived exclusively from public data — no proprietary estimates.

Profit margin near 0.7% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $4.75B supports balance-sheet flexibility.

CAH — Growth Outlook

Growth outlook for Cardinal Health, Inc. (CAH) depends on demand trends in Medical Distribution and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 5.8% suggests steady but measured expansion.
• Earnings growth of 68.8% year-over-year supports improving profitability.
• Price is 14.3% below the 52-week high.

CAH — Competitive Position

Cardinal Health, Inc. (CAH) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Medical Distribution.
• Market capitalization of $51.24B places CAH among large-cap peers.
• Gross margin of 3.8% should be benchmarked against direct competitors.

CAH — Summary

Cardinal Health, Inc. (CAH) is a large-cap Healthcare company focused on Medical Distribution, listed on NYQ. Last price $221.27 with market cap $51.24B. Trailing P/E 30.69×. Revenue grew 5.8% year-over-year per public data. Notable strengths include revenue growth of 5.8% year-over-year. Key watch items include thin profit margin (0.7%). Premium Terminal tools for Cardinal Health, Inc. add ownership analytics, news, and richer estimate history beyond this public summary.